Spectral Medical Inc.
EDT.TO
TSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 47.42% | -13.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 47.42% | -13.50% | |||
| Cost of Revenue | 13.06% | -4.96% | |||
| Gross Profit | 77.55% | -19.81% | |||
| SG&A Expenses | -22.43% | 34.29% | |||
| Depreciation & Amortization | -34.27% | -33.33% | |||
| Other Operating Expenses | 0.24% | 43.71% | |||
| Total Operating Expenses | -19.97% | 29.71% | |||
| Operating Income | 30.64% | -40.85% | |||
| Income Before Tax | 84.09% | -489.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 84.09% | -489.22% | |||
| Earnings from Discontinued Operations | -- | 27.59% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 84.09% | -489.81% | |||
| EBIT | 30.64% | -40.85% | |||
| EBITDA | 30.83% | -41.42% | |||
| EPS Basic | 84.09% | -489.87% | |||
| Normalized Basic EPS | 83.94% | -486.00% | |||
| EPS Diluted | 84.09% | -489.87% | |||
| Normalized Diluted EPS | 83.94% | -486.00% | |||
| Average Basic Shares Outstanding | 0.05% | 0.44% | |||
| Average Diluted Shares Outstanding | 0.05% | 0.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||